KSM66 – a safety evaluation

2024-03-12

After an incorrect risk assessment by the Danish National Food Administration regarding the safety of ashwagandha root - where, based on mainly small animal studies on leaves and stems, they incorrectly concluded that ashwagandha root can have negative effects, we have chosen to publish a complete safety assessment of KSM66. The most used and clinical studied ashwagandha in the world.

For more information, contact Tom Johnsson, head of R&D: +46705949195, tom@medicinegarden.se

Download:

-> KSM66_Safety_Studies_March 2024_English.pdf

-> Appendix 1_SAFETY EVALUATION_ROOT PART VS. AERIAL PARTS.pdf

-> Appendix 2_Safety Opinion of Standardized Ashwagandha Root Extract.pdf

-> Appendix 3_KSM66_Studies_Safety_050324.xlsx

-> Appendix 4_Withania Safety Review AHP 2024.pdf

Har du några frågor?
Är det något du undrar över? ring eller maila, så hjälper vi dig gärna.
Kontakta oss